Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK)
ConditionRadiotherapy Side Effect
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Aarhus
About this trial
The study aims to provide a setup for collecting radiotherapy-related toxicity data, loco-regional control, and overall survival data for all Danish cancer patients undergoing reirradiation with high dose intention or with the aim of local tumour control; with the ultimate aim of providing safe reirradiation to a larger group of patients. To build a reirradiation cohort database for future research
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
High dose reirradiation (reirradiation type I or II or repeat organ irradiation delivered with the aim of local control)
Disqualifiers
The primary and reirradiation treatments may not be quasi-simultaneous (i.e. the two treatments should be planned independently)
Trial population
No guidelines are provided on the selection of patients for high dose reirradiation. All patients are eligible for the database if treated with reirradiation with the aim of local control.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Reirradiation
Radiationreirradiation with all available modalities can be included
Treatment groups
500 Participants
are divided into 1 treatment groupGroup A: Reirradiation1 intervention
Trial outcomes
Primary outcomes
1
Side effects
CTCAE side effects
Time frame
5 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: